Company profile
UK company 08166456, incorporated on 2 August 2012.
Antibody Sequencing, Engineering & Expression | Absolute Antibody
Absolute Antibody specializes in the sequencing, engineering, and recombinant production of antibodies. If you can describe it, we can make it.
Company number 08166456
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AP01 | Transaction MzUzNzAxOTc3NGFkaXF6a2N4
Published 04 Aug 2026 16:41
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Oct 2020 to 30 Sep 2022
Awaiting Public Project Summary
1 Dec 2018 to 28 Feb 2021
"POCKiT diagnostics is a UK company focused on the research and development of point-of-care diagnostic devices. Our main target is to develop a device for diagnosis of brain stroke. Stroke is the third leading cause of death and the first cause of physical disability and dementia worldwide. In stroke, the brain is damaged by restricted blood flow to the ...
1 Mar 2018 to 28 Feb 2019
A platform for rapidly producing rationally engineered vaccines is urgently required to combat the threat of epidemic or pandemic pathogen outbreaks. Most existing vaccines are multicomponent products that are challenging to manufacture. The slowest step is typically transfer from preclinical proof-of-concept to GMP manufacture for human use. Manufacturin...
1 Feb 2017 to 28 Feb 2021
Awaiting Public Project Summary
1 May 2013 to 30 Apr 2014
Antibodies are outstanding tools for biomedical research and essential components of a myriad of diagnostic tests. They are also the largest and fastest growing source of new drugs with 39 approved to date and hundreds more in the pipeline. The vast majority of therapeutic antibodies are made using recombinant DNA technology, which has enabled the enginee...
